An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)
Use of Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Italy: an Observational Cohort Study
1 other identifier
observational
437
1 country
72
Brief Summary
This observational, multicenter, retrospective/prospective study will evaluate the use of Avastin (bevacizumab) in clinical practice in patients with metastatic colorectal cancer. Patients having initiated first-line treatment with a fluoropyrimidine-based chemotherapy and Avastin will be followed for up to 15 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
Shorter than P25 for all trials
72 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2012
CompletedFirst Posted
Study publicly available on registry
May 31, 2012
CompletedStudy Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedNovember 2, 2016
November 1, 2016
1 year
May 29, 2012
November 1, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients with Avastin treatment discontinuation due to either disease progression or Avastin-related adverse events
approximately 15 months
Secondary Outcomes (4)
Proportion of patients with treatment discontinuation due to other causes
approximately 15 months
Incidence of other causes for treatment discontinuation
approximately 15 months
Second-line treatments initiated
approximately 15 months
Progression-free survival (patients with treatment discontinuation due to disease progression or Avastin-related toxicity as compared to patients with treatment discontinuation due to other causes)
approximately 15 months
Study Arms (1)
Cohort
Eligibility Criteria
Patients with metastatic colorectal cancer having initiated first-line treatment with fluoropyrimidine-based chemotherapy and Avastin
You may qualify if:
- Adult patients, \>/= 18 years of age
- Metastatic colorectal cancer
- Having initiated first-line treatment with fluoropyrimidine-based chemotherapy plus Avastin between 1. September 2011 and 29. February 2012
- Availability of test fro K-RAS genotyping
You may not qualify if:
- Participation in a clinical trial during treatment with Avastin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (72)
Unknown Facility
L’Aquila, Abruzzo, 67010, Italy
Unknown Facility
Teramo, Abruzzo, 64100, Italy
Unknown Facility
Brindisi, Apulia, 72100, Italy
Unknown Facility
Castellana Grotte (BA), Apulia, 70013, Italy
Unknown Facility
Foggia, Apulia, 71100, Italy
Unknown Facility
Lecce, Apulia, 73100, Italy
Unknown Facility
San Giovanni Rotondo, Apulia, 71013, Italy
Unknown Facility
Rionero in Vulture, Basilicate, 85028, Italy
Unknown Facility
Cosenza, Calabria, 87100, Italy
Unknown Facility
Lamezia Terme (CZ), Calabria, 88046, Italy
Unknown Facility
Reggio Calabria, Calabria, 89100, Italy
Unknown Facility
Benevento, Campania, 82100, Italy
Unknown Facility
Napoli, Campania, 80100, Italy
Unknown Facility
Napoli, Campania, 80131, Italy
Unknown Facility
Pagani ( Sa), Campania, 84016, Italy
Unknown Facility
Imola (BO), Emilia-Romagna, 40026, Italy
Unknown Facility
Modena, Emilia-Romagna, 41100, Italy
Unknown Facility
Parma, Emilia-Romagna, 43100, Italy
Unknown Facility
Pordenone, Friuli Venezia Giulia, 33170, Italy
Unknown Facility
Albano Laziale, Lazio, 00041, Italy
Unknown Facility
Rome, Lazio, 00128, Italy
Unknown Facility
Rome, Lazio, 00157, Italy
Unknown Facility
Rome, Lazio, 00185, Italy
Unknown Facility
Rome, Lazio, 00189, Italy
Unknown Facility
Sora, Lazio, 03039, Italy
Unknown Facility
Viterbo, Lazio, 01100, Italy
Unknown Facility
Genoa, Liguria, 16132, Italy
Unknown Facility
La Spezia, Liguria, 19100, Italy
Unknown Facility
Savona, Liguria, Italy
Unknown Facility
Bergamo, Lombardy, 24121, Italy
Unknown Facility
Brescia, Lombardy, 25124, Italy
Unknown Facility
Cremona, Lombardy, 26100, Italy
Unknown Facility
Lecco, Lombardy, 23900, Italy
Unknown Facility
Milan, Lombardy, 20099, Italy
Unknown Facility
Milan, Lombardy, 20142, Italy
Unknown Facility
Monza, Lombardy, 20900, Italy
Unknown Facility
Pavia, Lombardy, 27100, Italy
Unknown Facility
S. Fermo Della Battaglia (CO), Lombardy, 22020, Italy
Unknown Facility
Saronno, Lombardy, 21047, Italy
Unknown Facility
Varese, Lombardy, 21100, Italy
Unknown Facility
Cuneo, Piedmont, 12100, Italy
Unknown Facility
Novara, Piedmont, 28100, Italy
Unknown Facility
Orbassano, Piedmont, 10043, Italy
Unknown Facility
Ponderano (BI), Piedmont, 13875, Italy
Unknown Facility
Turin, Piedmont, 10126, Italy
Unknown Facility
Turin, Piedmont, 10153, Italy
Unknown Facility
Cagliari, Sardinia, 09121, Italy
Unknown Facility
Sassari, Sardinia, 07100, Italy
Unknown Facility
Catania, Sicily, 95123, Italy
Unknown Facility
Cefalù, Sicily, 90015, Italy
Unknown Facility
Messina, Sicily, 98125, Italy
Unknown Facility
Messina, Sicily, 98158, Italy
Unknown Facility
Palermo, Sicily, 90100, Italy
Unknown Facility
Taormina, Sicily, 98030, Italy
Unknown Facility
Vimercate, Sicily, 20059, Italy
Unknown Facility
Fano, The Marches, 61032, Italy
Unknown Facility
Fermo, The Marches, 63023, Italy
Unknown Facility
Macerata, The Marches, 62100, Italy
Unknown Facility
Grosseto, Tuscany, 58100, Italy
Unknown Facility
Lido di Camaiore, Tuscany, 55043, Italy
Unknown Facility
Livorno, Tuscany, 57100, Italy
Unknown Facility
Pontedera, Tuscany, 56025, Italy
Unknown Facility
Siena, Tuscany, 53100, Italy
Unknown Facility
Perugia, Umbria, 06156, Italy
Unknown Facility
Cona (Ferrara), Veneto, 44124, Italy
Unknown Facility
Este, Veneto, 35042, Italy
Unknown Facility
Este (PD), Veneto, 35042, Italy
Unknown Facility
Mirano, Veneto, 30035, Italy
Unknown Facility
Montecchio Maggiore, Veneto, 36075, Italy
Unknown Facility
Padua, Veneto, 35128, Italy
Unknown Facility
Rovigo, Veneto, 45100, Italy
Unknown Facility
Treviso, Veneto, 31100, Italy
Related Publications (1)
Lonardi S, Nasti G, Fagnani D, Gemma D, Ciuffreda L, Granetto C, Lucchesi S, Ballestrero A, Biglietto M, Proserpio I, Bergamo F, Proietti E, Tonini G. Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study. Tumori. 2019 Jun;105(3):243-252. doi: 10.1177/0300891619834126. Epub 2019 Mar 11.
PMID: 30857495DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Trials
Hoffmann-La Roche
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 29, 2012
First Posted
May 31, 2012
Study Start
June 1, 2012
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
November 2, 2016
Record last verified: 2016-11